arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2408.03586cs.HC
收藏

癌症治疗诱发心脏毒性决策中的临床挑战与人工智能机遇

Clinical Challenges and AI Opportunities in Decision-Making for Cancer Treatment-Induced Cardiotoxicity

Siyi Wu, Weidan Cao, Shihan Fu, Bingsheng Yao, Ziqi Yang, Changchang Yin, Varun Mishra, Daniel Addison, Ping Zhang, Dakuo Wang

AI总结:

本研究通过访谈七位临床专家,识别出癌症治疗诱发心脏毒性临床决策的三步范式,揭示诊断与症状监测中的关键挑战,并提出面向远程监测和早期检测的数字工具设计考量。

摘要:

癌症治疗诱发的心脏毒性已成为一个重要的临床问题,影响癌症患者的长期生存率和生活质量。有效的临床决策,包括检测癌症治疗诱发的心脏毒性以及监测相关症状,对临床医生而言仍是一项具有挑战性的任务。本研究调查了临床医生在癌症治疗诱发心脏毒性临床决策中的当前实践与需求,并探讨了数字健康技术支持这一过程的潜力。通过对七位临床专家进行半结构化访谈,我们识别出一个三步决策范式:1)症状识别,2)诊断检测与专科协作,以及3)临床决策与干预。我们的研究结果凸显了诊断心脏毒性的困难(缺乏统一方案且症状变异性高)以及监测患者症状的困难(缺乏准确、及时的患者自我报告症状)。临床医生还表达了他们对能够整合远程患者监测能力的有效早期检测工具的需求。基于这些见解,我们讨论了理解临床工作流程动态特性的重要性,以及未来数字工具支持癌症治疗诱发心脏毒性决策的设计考量。

英文摘要:

Cardiotoxicity induced by cancer treatment has become a major clinical concern, affecting the long-term survival and quality of life of cancer patients. Effective clinical decision-making, including the detection of cancer treatment-induced cardiotoxicity and the monitoring of associated symptoms, remains a challenging task for clinicians. This study investigates the current practices and needs of clinicians in the clinical decision making of cancer treatment-induced cardiotoxicity and explores the potential of digital health technologies to support this process. Through semi-structured interviews with seven clinical experts, we identify a three-step decision-making paradigm: 1) symptom identification, 2) diagnostic testing and specialist collaboration, and 3) clinical decision-making and intervention. Our findings highlight the difficulties of diagnosing cardiotoxicity (absence of unified protocols and high variability in symptoms) and monitoring patient symptoms (lacking accurate and timely patient self-reported symptoms). The clinicians also expressed their need for effective early detection tools that can integrate remote patient monitoring capabilities. Based on these insights, we discuss the importance of understanding the dynamic nature of clinical workflows, and the design considerations for future digital tools to support cancer-treatment-induced cardiotoxicity decision-making.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑